Cargando…
Phasing out the pre-transplant cytotoxicity crossmatch: Are we missing something?
INTRODUCTION: The anti-human globulin-enhanced complement-dependent cytotoxicity crossmatch (AHG-CDCXM) assay has been used to assess the presence of donor-specific antibodies (DSA) in recipient’s serum before kidney transplantation. The flow cytometric crossmatch (FCXM) assay was first introduced a...
Autores principales: | Abud, Jamile, Pupo, Bruna Brasil Dal, da Silva, Cynthia, Keitel, Elizete, Garcia, Valter Duro, Manfro, Roberto Ceratti, Neumann, Jorge |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Nefrologia
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8428636/ https://www.ncbi.nlm.nih.gov/pubmed/33899906 http://dx.doi.org/10.1590/2175-8239-JBN-2019-0222 |
Ejemplares similares
-
Are We Missing Out on Something?
por: Kapoor, Astha Koolwal, et al.
Publicado: (2018) -
Funding for kidney transplantation
por: Garcia, Valter Duro, et al.
Publicado: (2021) -
Usefulness of Kidney Donor Profile Index (KDPI) to predict graft survival in a South Brazilian Cohort
por: Prado, Natália Petter, et al.
Publicado: (2020) -
Left Ventricular Diastolic Parameters in Dilated Cardiomypoathy: Are We Missing Out on Something?
por: Kashyap, Raghava, et al.
Publicado: (2014) -
Effect of conversion from calcineurin inhibitors to everolimus on
hepatitis C viremia in adult kidney transplant recipients
por: Pacheco, Larissa Sgaria, et al.
Publicado: (2018)